(The drugs are not yet commonly
used against malaria.)
«We've been trying to treat it with the drugs
used against malaria, but it would be better to use those drugs that are used on fungi.
Not exact matches
A commonly
used anti-parasite drug could be the next weapon in the fight
against malaria.
Preliminary results of the study were presented at a World Health Organization (WHO) evidence review group meeting, while UNITAID has issued a call for further research into the
use of endectocide class drugs, of which ivermectin is currently the only one registered for human
use, as new vector control tools in the fight
against malaria and other mosquito borne disease.
Researchers at Stanford University purified the proteasome from the
malaria parasite and examined its activity
against hundreds of different peptide sequences
using a novel method developed at the University of California, San Francisco.
This structure (bottom left) of the
malaria parasite's proteasome, obtained
using the revolutionary Cryo - Electron Microscopy technique, enabled the design of a specific inhibitor (front)
against the mosquito - borne
malaria parasite (pictured at back).
Used strategically throughout the tropical world, the bacteria could become a practical tool in the fight
against malaria, helping to stop mosquitoes from spreading the disease to some of the 250 million people worldwide who currently contract it every year.
Worse still, the results suggest it would be a mistake to
use adenovirus - based vaccines
against other diseases, such as
malaria or tuberculosis, in areas where HIV is common.
We've already moved away from
using quinine to treat cases as the
malaria parasite has become more resistant to it, but if further drug resistance were to develop
against our most valuable
malaria drug, artemisinin, we would be facing a grave situation.
Using the same method, a Helicobacter vaccine
against malaria would be dirt cheap.
Candidate vaccines
against Ebola or
malaria — one of which recently received an important stamp of approval in Europe — should definitely be
used if they are safe and effective, he says, but they could lead to more virulent pathogens.
The studies support the concept of
using natural exposure in combination with
malaria - fighting drugs to help people build up protection
against disease, says
malaria vaccine researcher Robert Sauerwein of the Radboud University Nijmegen Medical Center in the Netherlands.
Most other vaccine trials have tried to
use the
malaria parasite — rather than the body's reaction
against it — to find possible targets for vaccines.
Achieving a milestone in the fight
against malaria, scientists at Amyris Biotechnologies have produced 25 g / L of amorphadiene, a precursor of the antimalarial agent artemisinin, by
using synthetic biology and E. coli fermentations...
Her research involves preclinical immunology and efficacy of vaccines
against H5N1 pandemic influenza,
malaria, and Mycobacterium tuberculosis
using mouse, ferret and guinea pig models.
April 17, 2018 - The «newest frontier»
against malaria is gathering data about
malaria cases, and by
using digital surveillance, such as GPS tracking the locations of where those infected are, said Bill Gates.
The research of the Department of Parasitology is focused on developing vaccines and drugs
against malaria and TB,
using non-human primate models.
Safety and efficacy concerns with currently
used drugs accentuate the need for new chemotherapeutic options
against severe
malaria.
It is also
used against many other infections including the flu, urinary tract infections, vaginal yeast infections, genital herpes, bloodstream infections (septicemia), gum disease, tonsillitis, streptococcus infections, syphilis, typhoid,
malaria, and diphtheria.
Echinacea is also
used against many other infections including the flu, urinary tract infections, vaginal yeast infections, genital herpes, bloodstream infections (septicemia), gum disease, tonsillitis, streptococcus infections, syphilis, typhoid,
malaria, and diphtheria.
In particular, these handouts cover the following specific content about tuberculosis in South Africa: Case study of one communicable disease, such as
malaria or tuberculosis, at a country scale, either an LIDC or EDC, including: o environmental and human causes of the disease o prevalence, incidence and patterns of the disease o socio - economic impacts of the disease o direct and indirect strategies
used by government and international agencies to mitigate
against the disease and respond to outbreaks.
And despite the fact that DDT has been associated with other ill - health effects as well, like Alzheimer's disease, obesity, and kidney and ovarian diseases, a number of countries still
use it in the war
against malaria.
Some potential discouraging news in the worldwide battle
against malaria: A report from Senegal shows that mosquitos can rapidly develop resistance to insecticide
used to impregnate bed nets.